StonvexLoading…
StonvexStonvexStonvexCore line items from VZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $34.44B | $138.19B | $101.81B | $67.99B |
Operating Income | $8.24B | $29.26B | $24.25B | $16.15B |
Net Income | $5.04B | $17.17B | $14.83B | $9.88B |
EPS (Diluted) | $1.20 | $4.06 | $3.51 | $2.34 |
Total Assets | $417.88B | $404.26B | $388.33B | $383.29B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $8.37B | $19.05B | $7.71B | $3.44B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 4.21B | 4.23B | 4.23B | 4.23B |